18 sept. 2026•3 min de lecture
FDA Grants Approval for Ethosuximide 250 mg Oral Capsules (ANDA 211928)
The FDA has approved ANDA 211928 for 250 mg oral capsules of ethosuximide, manufactured by Strides Pharma Science Limited and sponsored by ONESOURCE.